PUBLIC COMPANY

$ANVSAnnovis Bio, Inc.

Malvern, PA, USupdated 1mo ago

SEC EDGAR Yahoo Finance

community read0 votes

pipeline

1

marketed

0

phase 3

1

catalysts ytd

0

approvals ytd

0

recalls ytd

0

Pipeline(1)

pipeline depth1 products

1Phase 3

Phase 3

buntanetap tartrate

Parkinson's Disease

Upcoming

no upcoming catalysts on record

Recent(90d)

nothing in the last 90 days

view all catalysts →

🐶 Hiring Signal

No open roles indexed yet — view Annovis Bio, Inc. jobs →

News

no news has mentioned this company yet

Active trials

phase3A Double-blind Dual Study Assessing Safety and Efficacy of Buntanetap in Participants With Early ADrecruitingn=760
phase3A Study of Buntanetap in Participants With PDrecruitingn=500
phase3A Dose-ranging Study to Investigate Efficacy of Buntanetap in Mild to Moderate ADcompletedn=351
phase3A Double-blind Study to Investigate Efficacy and Safety of Buntanetap Compared With Placebo in Participants With Early PDcompletedn=523

$ANVS

Insider activity

source: SEC Form 4

open-market buys + sells

Apr 2, 26BUYHoffman Michael B· 713,800 sh @ $2.10$1.50M↗

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Data sources

SEC EDGAR

last refreshed 1m ago

Found something off?